Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Life Science Integrates

  1. Events
  2. Organisers
  3. Life Science Integrates
Events from this organiser
Today

Advanced Therapies Integrates North 2025

Advanced Therapies Integrates North 2025 brings together industry leaders to unlock the full potential of Advanced Therapies and Medicinal Products (ATMPs). The event spotlights key [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top